These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14711507)

  • 1. N-terminal truncation circumvents proteolytic degradation of the human HtrA2/Omi serine protease in Escherichia coli: rapid purification of a proteolytically active HtrA2/Omi.
    Seong YM; Park HJ; Seong GH; Choi JY; Yoon SJ; Min BR; Kang S; Rhim H
    Protein Expr Purif; 2004 Feb; 33(2):200-8. PubMed ID: 14711507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity of the region encoded by exon8 of the human serine protease, HtrA2/Omi, is associated with its protein solubility.
    Park HJ; Choi JY; Seong YM; Han C; Yoon SJ; Kang S; Rhim H
    Biotechnol Lett; 2003 Oct; 25(19):1597-603. PubMed ID: 14584913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi.
    Martins LM; Turk BE; Cowling V; Borg A; Jarrell ET; Cantley LC; Downward J
    J Biol Chem; 2003 Dec; 278(49):49417-27. PubMed ID: 14512424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocatalytic processing of HtrA2/Omi is essential for induction of caspase-dependent cell death through antagonizing XIAP.
    Seong YM; Choi JY; Park HJ; Kim KJ; Ahn SG; Seong GH; Kim IK; Kang S; Rhim H
    J Biol Chem; 2004 Sep; 279(36):37588-96. PubMed ID: 15201285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-terminal tail of presenilin regulates Omi/HtrA2 protease activity.
    Gupta S; Singh R; Datta P; Zhang Z; Orr C; Lu Z; Dubois G; Zervos AS; Meisler MH; Srinivasula SM; Fernandes-Alnemri T; Alnemri ES
    J Biol Chem; 2004 Oct; 279(44):45844-54. PubMed ID: 15294909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2.
    Srinivasula SM; Gupta S; Datta P; Zhang Z; Hegde R; Cheong N; Fernandes-Alnemri T; Alnemri ES
    J Biol Chem; 2003 Aug; 278(34):31469-72. PubMed ID: 12835328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif.
    Martins LM; Iaccarino I; Tenev T; Gschmeissner S; Totty NF; Lemoine NR; Savopoulos J; Gray CW; Creasy CL; Dingwall C; Downward J
    J Biol Chem; 2002 Jan; 277(1):439-44. PubMed ID: 11602612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
    Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
    Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212.
    Yang L; Sun M; Sun XM; Cheng GZ; Nicosia SV; Cheng JQ
    J Biol Chem; 2007 Apr; 282(15):10981-7. PubMed ID: 17311912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria.
    Mandel H; Saita S; Edvardson S; Jalas C; Shaag A; Goldsher D; Vlodavsky E; Langer T; Elpeleg O
    J Med Genet; 2016 Oct; 53(10):690-6. PubMed ID: 27208207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2.
    Cilenti L; Lee Y; Hess S; Srinivasula S; Park KM; Junqueira D; Davis H; Bonventre JV; Alnemri ES; Zervos AS
    J Biol Chem; 2003 Mar; 278(13):11489-94. PubMed ID: 12529364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain.
    Zhang Y; Appleton BA; Wu P; Wiesmann C; Sidhu SS
    Protein Sci; 2007 Aug; 16(8):1738-50. PubMed ID: 17656586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases.
    Goo HG; Rhim H; Kang S
    Curr Protein Pept Sci; 2017; 18(7):746-757. PubMed ID: 26965693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
    Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
    Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.
    Kieper N; Holmström KM; Ciceri D; Fiesel FC; Wolburg H; Ziviani E; Whitworth AJ; Martins LM; Kahle PJ; Krüger R
    Exp Cell Res; 2010 Apr; 316(7):1213-24. PubMed ID: 20064504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid characterization of the binding property of HtrA2/Omi PDZ domain by validation screening of PDZ ligand library.
    Ma S; Song E; Gao S; Tian R; Gao Y
    Sci China C Life Sci; 2007 Jun; 50(3):412-22. PubMed ID: 17609899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis.
    Sosna J; Voigt S; Mathieu S; Kabelitz D; Trad A; Janssen O; Meyer-Schwesinger C; Schütze S; Adam D
    Cell Commun Signal; 2013 Oct; 11():76. PubMed ID: 24090154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome-wide Identification of HtrA2/Omi Substrates.
    Vande Walle L; Van Damme P; Lamkanfi M; Saelens X; Vandekerckhove J; Gevaert K; Vandenabeele P
    J Proteome Res; 2007 Mar; 6(3):1006-15. PubMed ID: 17266347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific protein interaction of human Pag with Omi/HtrA2 and the activation of the protease activity of Omi/HtrA2.
    Hong SK; Cha MK; Kim IH
    Free Radic Biol Med; 2006 Jan; 40(2):275-84. PubMed ID: 16413409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15.
    Trencia A; Fiory F; Maitan MA; Vito P; Barbagallo AP; Perfetti A; Miele C; Ungaro P; Oriente F; Cilenti L; Zervos AS; Formisano P; Beguinot F
    J Biol Chem; 2004 Nov; 279(45):46566-72. PubMed ID: 15328349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.